Global Biopharmaceuticals Contract Manufacturing Market

Biopharmaceuticals Contract Manufacturing Market Size, Share, Growth Analysis, By Source(Mammalian, Non-mammalian), By Service(Process Development, Fill & Finish Operations, Packaging, others), By Product Type(Interferon, Monoclonal Antibodies, Protein, Vaccines), By Therapeutic Applications(Oncology, Cardiovascular Diseases, Others), By Region - Industry Forecast 2025-2032


Report ID: SQSG35H2019 | Region: Global | Published Date: April, 2024
Pages: 157 | Tables: 120 | Figures: 77

Biopharmaceuticals Contract Manufacturing Market News

  • In January 2022, INCOG BioPharma Services, an Indian-based contract development and manufacturing company, specialized in sterile injectables, announced the completion of its new manufacturing facility and global headquarters in Fisher.
  • In March 2021, JSR Pharma, announced the launch of its new corporate venture fund mainly focusing on various emerging biotech, engaging customers to their improved life sciences services portfolio. The new venture enable company to expand its revenue generation by offering innovated services to the global consumers.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Biopharmaceuticals Contract Manufacturing Market size was valued at USD 17.88 Billion in 2023 and is poised to grow from USD 18.81 Billion in 2024 to USD 29.69 Billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

Global biopharmaceuticals contract manufacturing market is consolidated in nature with the presence of several large market players operating across the globe. And, in terms of market share, top 5 players of the market are dominating the market including Boehringer Ingelheim, JSR Pharma, and Inno Biologics Sdn Bhd. These players are highly focusing on few business developing strategies including collaborations, mergers, new product innovations, and advance technology adoption to expand their geographical presence and product offerings. 'Boehringer Ingelheim GmbH', 'Catalent', 'Lonza Group AG', 'Thermo Fisher Scientific Inc.', 'Samsung BioLogics Co. Ltd.', 'Fujifilm Diosynth Biotechnologies', 'WuXi Biologics (Cayman) Inc.', 'AbbVie Inc.', 'AGC Biologics', 'Baxter BioPharma Solutions', 'Biocon Ltd.', 'Cytovance Biologics Inc.', 'Eurofins Scientific SE', 'Genscript Biotech Corporation', 'Grifols SA', 'Innovent Biologics (Suzhou) Co. Ltd.', 'JSR Corporation', 'KBI Biopharma Inc.', 'Merck KGaA', 'Novasep Holding SAS'

Increasing Demand for Biological Therapies

Introduction of AI Boosting Biopharmaceuticals Contract Manufacturing Market Growth

Globally, North America region dominated the biopharmaceuticals contract manufacturing with a holding of strong market share in 2021 due to the large number of biomanufacturing facilities in the United States. Additionally, interventions & conferences conducted in the North America for pertinent developing technologies and major issues in applications of biologics for the better treatment of several chronic disorders are likely to fuel the adoption of contract manufacturing services in the region over the coming years.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Biopharmaceuticals Contract Manufacturing Market

Report ID: SQSG35H2019

$5,300
BUY NOW GET FREE SAMPLE